Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

Printable VAX Fact Who Can Get the Vaccine Now?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Printable VAX Fact How Much will the COVID-19 Vaccine Cost?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Printable VAX Fact When can I get the COVID-19 Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Printable VAX Fact Where can I get the COVID-19 Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Printable VAX Fact Do I Have to Get the COVID-19 Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

Printable VAX Fact Do I Still Need to Wear a Facemask After I'm Vaccinated?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit | COVID-19 Vax Facts

MHS Minute: A Path Forward in 2021

Video
2/10/2021
DHA Seal

Want to know more about what MHS organizations and partners did in 2020? For a full look at the MHS Minute series, click here: https://shorturl.at/eDL14

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

COVID-19 vaccinations reaching smaller clinics, facilities

Article
2/10/2021
Military healthcare worker holding a vaccine needle

The pace of vaccinations should accelerate as the FDA approves newer vaccines for use.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

COVID-19 vaccine rollout ongoing in U.S. Army Central footprint

Article
2/9/2021
Two healthcare workers, wearing masks, adding the COVID-19 vaccine to syringes

The COVID-19 vaccination program in the U.S. Army Central’s area of operations is underway.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DOD Announces Use of Masks, Other Public Health Measures

Article
2/9/2021
Woman wearing a mask

Department of Defense updates the use of masks requirements to align to the most current CDC guidelines.

Recommended Content:

Coronavirus | COVID-19 Toolkit

Military, medical leaders discuss COVID-19 issues with Service Members

Article
2/8/2021
Mr. and Mrs. Milley, wearing masks, standing in front of various flags.

Fauci said it is impossible to get COVID-19 from the vaccine, and it will "absolutely not" enter into a person's DNA.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DOD COVID-19 vaccine roll-out continues, eye on long-term readiness

Article
2/4/2021
Soldier getting a vaccine in his left arm

The impact of the COVID-19 vaccines on military readiness is unknown, but members are encouraged to get the shots as soon as they become available.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

Eliminating the pandemic - one shot at a time

Article
2/3/2021
Tom Danaher was one of approximately several hundred 75 years and older beneficiaries who were administered their initial dose of Moderna COVID-19 vaccine.

NHB / NMRTC Bremerton moves forward with the phased approach of the COVID-19 vaccines

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Blood donations remain vital for Service Member care

Article
2/3/2021
Man walking with assistance at a PT clinic

Putting a human face on the act of giving blood could help drive blood donations. And first-tme donors often become sustaining donors.

Recommended Content:

Holiday Observances | Coronavirus | Convalescent Plasma Collection Program
<< < 1 2 3 4 5  ... > >> 
Showing results 16 - 30 Page 2 of 28

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.